News from NORD

Alpha-1 Foundation Announces Funding Opportunities

Publish date: August 9, 2017

 

The Alpha-1 Foundation has announced its funding opportunities in its 2017-2018 grants cycle. In-cycle Letters of Intent are due by September 22, 2017, and may be submitted online.

Recommended Reading

TRK inhibitor shows ‘striking’ activity, durability across diverse adult and pediatric cancers
MDedge Hematology and Oncology
Blood markers can detect early pancreatic cancer
MDedge Hematology and Oncology
Bone marrow transplantation for epidermolysis bullosa continues to evolve
MDedge Hematology and Oncology
Preview Agenda for NORD’s 2017 Rare Diseases and Orphan Products
MDedge Hematology and Oncology
FDA Commissioner to Present Keynote Address at NORD Summit
MDedge Hematology and Oncology
Examining the Role of Caregivers at NINR Caregiving Summit
MDedge Hematology and Oncology
FDA Launches Expanded Access Navigator
MDedge Hematology and Oncology
Columbia Neurosurgery Article Highlights Medical Expert’s Support for NORD Patient Information
MDedge Hematology and Oncology
AA MDS Offers Webinar Series
MDedge Hematology and Oncology
NORD Welcomes All Things Kabuki as New Member
MDedge Hematology and Oncology